• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞色素P450系统中的定量构效关系(QSARs):描述P450底物结合、抑制和诱导的QSARs。

Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s.

作者信息

Lewis David F V

机构信息

School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK.

出版信息

Inflammopharmacology. 2003;11(1):43-73. doi: 10.1163/156856003321547112.

DOI:10.1163/156856003321547112
PMID:15035734
Abstract

Quantitative structure-activity relationships (QSARs) within substrates, inducers and inhibitors of cytochromes P450 involved in xenobiotic metabolism are reported, together with QSARs associated with induction, inhibition and metabolic rate. The importance of frontier orbitals and shape descriptors, such as planarity (estimated by the area/depth(2) parameter) and rectangularity (estimated by the length/width parameter) is discussed, particularly in the context of the COMPACT system which discriminates between several P450 families associated with the activation and detoxication of xenobiotics. The use of parameters, particularly those derived from homology modelling of mammalian (especially human) P450s that are involved in exogenous metabolism, in generating QSARs for P450 substrates is discussed in the context of explaining differences in the binding affinities of human P450 substrates which are pharmacologically active.

摘要

本文报道了参与异源物代谢的细胞色素P450底物、诱导剂和抑制剂中的定量构效关系(QSARs),以及与诱导、抑制和代谢速率相关的QSARs。讨论了前沿轨道和形状描述符的重要性,如平面度(由面积/深度(2)参数估计)和矩形度(由长度/宽度参数估计),特别是在COMPACT系统的背景下,该系统可区分与异源物激活和解毒相关的几个P450家族。在解释具有药理活性的人P450底物结合亲和力差异的背景下,讨论了参数的使用,特别是那些源自参与外源代谢的哺乳动物(尤其是人类)P450同源建模的参数,用于生成P450底物的QSARs。

相似文献

1
Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s.细胞色素P450系统中的定量构效关系(QSARs):描述P450底物结合、抑制和诱导的QSARs。
Inflammopharmacology. 2003;11(1):43-73. doi: 10.1163/156856003321547112.
2
Factors influencing rates and clearance in P450-mediated reactions: QSARs for substrates of the xenobiotic-metabolizing hepatic microsomal P450s.
Toxicology. 2002 Jan 15;170(1-2):45-53. doi: 10.1016/s0300-483x(01)00524-8.
3
Quantitative structure-activity relationships (QSARs) in inhibitors of various cytochromes P450: the importance of compound lipophilicity.
J Enzyme Inhib Med Chem. 2007 Feb;22(1):1-6. doi: 10.1080/14756360600952183.
4
Quantitative structure-activity relationships (QSARs) for inhibitors and substrates of CYP2B enzymes: importance of compound lipophilicity in explanation of potency differences.CYP2B 酶抑制剂和底物的定量构效关系(QSARs):化合物脂溶性在解释效价差异中的重要性。
J Enzyme Inhib Med Chem. 2010 Oct;25(5):679-84. doi: 10.3109/14756360903514149.
5
Quantitative structure--activity relationships for inducers of cytochromes P450 and nuclear receptor ligands involved in P450 regulation within the CYP1, CYP2, CYP3 and CYP4 families.细胞色素P450诱导剂以及参与CYP1、CYP2、CYP3和CYP4家族中P450调节的核受体配体的定量构效关系。
Toxicology. 2002 Jul 1;176(1-2):51-7. doi: 10.1016/s0300-483x(02)00135-x.
6
Structural characteristics of human P450s involved in drug metabolism: QSARs and lipophilicity profiles.参与药物代谢的人类细胞色素P450的结构特征:定量构效关系和脂溶性概况。
Toxicology. 2000 Apr 3;144(1-3):197-203. doi: 10.1016/s0300-483x(99)00207-3.
7
Quantitative structure-activity relationships (QSARs) within series of inhibitors for mammalian cytochromes P450 (CYPs).哺乳动物细胞色素P450(CYPs)抑制剂系列中的定量构效关系(QSARs)。
J Enzyme Inhib. 2001 Oct;16(4):321-30.
8
Quantitative structure-activity relationships within a homologous series of 7-alkoxyresorufins exhibiting activity towards CYP1A and CYP2B enzymes: molecular modelling studies on key members of the resorufin series with CYP2C5-derived models of human CYP1A1, CYP1A2, CYP2B6 and CYP3A4.对CYP1A和CYP2B酶具有活性的7-烷氧基试卤灵同系物的定量构效关系:用人CYP1A1、CYP1A2、CYP2B6和CYP3A4的CYP2C5衍生模型对试卤灵系列关键成员进行的分子模拟研究
Xenobiotica. 2004 Jun;34(6):501-13. doi: 10.1080/00498250410001691316.
9
Quantitative structure-activity relationships (QSARs) for substrates of human cytochromes P450 CYP2 family enzymes.
Toxicol In Vitro. 2004 Feb;18(1):89-97. doi: 10.1016/s0887-2333(03)00134-6.
10
P450 structures and oxidative metabolism of xenobiotics.细胞色素P450的结构与外源化合物的氧化代谢
Pharmacogenomics. 2003 Jul;4(4):387-95. doi: 10.1517/phgs.4.4.387.22752.

引用本文的文献

1
Addressing chemically-induced obesogenic metabolic disruption: selection of chemicals for human PPARα, PPARγ transactivation, and adipogenesis test methods.针对化学诱导的肥胖代谢紊乱的干预:用于人类 PPARα、PPARγ 转录激活和脂肪生成测试方法的化学物质选择。
Front Endocrinol (Lausanne). 2024 Jul 8;15:1401120. doi: 10.3389/fendo.2024.1401120. eCollection 2024.
2
Design, synthesis, and greener pasture biological assessment of a novel nucleoside: 1-(α-D-ribofuranosyl)-6,7-difluoro-2-methyl-4-quinazolinone as an inhibitor of COVID-19 and Alzheimer's disease.一种新型核苷的设计、合成及更环保的生物学评估:1-(α-D-呋喃核糖基)-6,7-二氟-2-甲基-4-喹唑啉酮作为新型冠状病毒肺炎和阿尔茨海默病的抑制剂
Turk J Chem. 2022 Jun 16;46(6):1827-1840. doi: 10.55730/1300-0527.3483. eCollection 2022.
3

本文引用的文献

1
Quantitative structure-activity relationship (QSAR) analysis for a series of rodent peroxisome proliferators: Interaction with the mouse liver peroxisome proliferator-activated receptor alpha (mPPARalpha).一系列啮齿动物过氧化物酶体增殖剂的定量构效关系(QSAR)分析:与小鼠肝脏过氧化物酶体增殖物激活受体α(mPPARα)的相互作用
Toxicol In Vitro. 1997 Feb-Apr;11(1-2):99-105. doi: 10.1016/s0887-2333(96)00067-7.
2
Molecular binding interactions: their estimation and rationalization in QSARs in terms of theoretically derived parameters.分子结合相互作用:依据理论推导参数在定量构效关系中对其进行估算及合理化分析。
ScientificWorldJournal. 2002 Jun 27;2:1776-802. doi: 10.1100/tsw.2002.343.
3
Novel saccharin analogs as promising antibacterial and anticancer agents: synthesis, DFT, POM analysis, molecular docking, molecular dynamic simulations, and cell-based assay.新型糖精类似物作为有前景的抗菌和抗癌剂:合成、密度泛函理论、多面体寡聚倍半硅氧烷分析、分子对接、分子动力学模拟及细胞实验
Front Pharmacol. 2022 Oct 4;13:958379. doi: 10.3389/fphar.2022.958379. eCollection 2022.
4
Novel 2-Hydroselenonicotinonitriles and Selenopheno[2, 3-b]pyridines: Efficient Synthesis, Molecular Docking-DFT Modeling, and Antimicrobial Assessment.新型2-氢硒代烟腈和硒吩并[2,3-b]吡啶:高效合成、分子对接-DFT建模及抗菌评估
Front Chem. 2021 May 10;9:672503. doi: 10.3389/fchem.2021.672503. eCollection 2021.
5
A New Family of Benzo[]Chromene Based Azo Dye: Synthesis, In-Silico and DFT Studies with In Vitro Antimicrobial and Antiproliferative Assessment.新型苯并[]色烯偶氮染料家族:合成、体内外抗菌和抗增殖评估的计算机辅助设计和密度泛函理论研究。
Int J Mol Sci. 2021 Mar 10;22(6):2807. doi: 10.3390/ijms22062807.
6
Design, Synthesis, Molecular Modeling, Anticancer Studies, and Density Functional Theory Calculations of 4-(1,2,4-Triazol-3-ylsulfanylmethyl)-1,2,3-triazole Derivatives.4-(1,2,4-三唑-3-基硫烷基甲基)-1,2,3-三唑衍生物的设计、合成、分子建模、抗癌研究及密度泛函理论计算
ACS Omega. 2020 Dec 31;6(1):301-316. doi: 10.1021/acsomega.0c04595. eCollection 2021 Jan 12.
7
Computational methods in drug discovery.药物发现中的计算方法。
Pharmacol Rev. 2013 Dec 31;66(1):334-95. doi: 10.1124/pr.112.007336. Print 2014.
8
Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies.通过定量构效关系研究获得的细胞色素 p450 酶和抑制剂的见解。
Molecules. 2012 Aug 3;17(8):9283-305. doi: 10.3390/molecules17089283.
9
Quantitative Property-Property Relationship for Screening-Level Prediction of Intrinsic Clearance of Volatile Organic Chemicals in Rats and Its Integration within PBPK Models to Predict Inhalation Pharmacokinetics in Humans.大鼠体内挥发性有机化合物内在清除率筛选水平预测的定量性质-性质关系及其在生理药代动力学(PBPK)模型中的整合,以预测人体吸入药代动力学
J Toxicol. 2012;2012:286079. doi: 10.1155/2012/286079. Epub 2012 May 22.
10
QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR.基于比较分子场分析、比较分子相似性指数分析和氢键量子形状分析的细胞色素 P450 酶 1A2 抑制剂的定量构效关系模型。
SAR QSAR Environ Res. 2011 Oct;22(7-8):681-97. doi: 10.1080/1062936X.2011.623320. Epub 2011 Oct 17.
Cytochromes P450, oxygen, and evolution.
细胞色素P450、氧气与进化
ScientificWorldJournal. 2001 Apr 4;1:151-67. doi: 10.1100/tsw.2001.22.
4
Baseline lipophilicity relationships in human cytochromes P450 associated with drug metabolism.与药物代谢相关的人类细胞色素P450中的基线亲脂性关联
Drug Metab Rev. 2003 Feb;35(1):1-18. doi: 10.1081/dmr-120018245.
5
A quantitative structure-activity relationship (QSAR) study of mutagenicity in several series of organic chemicals likely to be activated by cytochrome P450 enzymes.
Teratog Carcinog Mutagen. 2003;Suppl 1:187-93. doi: 10.1002/tcm.10073.
6
Molecular modelling of the human glucocorticoid receptor (hGR) ligand-binding domain (LBD) by homology with the human estrogen receptor alpha (hERalpha) LBD: quantitative structure-activity relationships within a series of CYP3A4 inducers where induction is mediated via hGR involvement.通过与人雌激素受体α(hERα)配体结合域(LBD)同源性对人糖皮质激素受体(hGR)配体结合域进行分子建模:一系列CYP3A4诱导剂中的定量构效关系,其中诱导作用通过hGR参与介导。
J Steroid Biochem Mol Biol. 2002 Oct;82(2-3):195-9. doi: 10.1016/s0960-0760(02)00158-9.
7
Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymes.对人CYP2家族酶的底物结合亲和力和选择性的基本要求。
Arch Biochem Biophys. 2003 Jan 1;409(1):32-44. doi: 10.1016/s0003-9861(02)00349-1.
8
Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template.基于CYP2C5晶体学模板对参与药物代谢的人类细胞色素P450进行建模。
J Inorg Biochem. 2002 Sep 20;91(4):502-14. doi: 10.1016/s0162-0134(02)00429-4.
9
Molecular orbital calculations and nicotine metabolism: a rationale for experimentally observed metabolite ratios.分子轨道计算与尼古丁代谢:实验观察到的代谢物比率的基本原理。
Drug Metabol Drug Interact. 2002;19(1):29-39. doi: 10.1515/dmdi.2002.19.1.29.
10
Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions.
Xenobiotica. 2002 Jul;32(7):547-61. doi: 10.1080/00498250210128693.